News | Cath Lab | November 21, 2016

Study Finds STEMI Post-conditioning is Not as Beneficial as Previously Believed

November 21, 2016 – A single-center study sponsored by the National Institutes of Health (NHLBI) failed to show an early benefit of postconditioning (the application of brief periods of ischemia during the initial phase of reperfusion) in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous intervention (PCI) and stenting. The study was conducted by researchers at the Minneapolis Heart Institute Foundation after their findings in a previously published small, nonrandomized study demonstrated that patients who underwent postconditioning had improved left ventricular (LV) function following their myocardial infarction.

Principal investigator Jay Traverse, M.D. developed the study to try and improve upon several previous trials from Europe and Asia that found postconditioning had mixed results in the setting of STEMI cases. “We sought to study the most optimal patient population with STEMI that could benefit from postconditioning to see if it is really effective,” Traverse said. “To accomplish that, we only enrolled patients with a totally occluded major coronary artery on presentation without evidence of collateral blood flow, with limited ishemic times between one and six hours and no evidence of pre-infarction angina, a powerful mitigator of infarct size. We also performed the postconditioning intervention immediately upon reperfusion with a guidewire, because the benefits of postconditioning in animals is lost if postconditioning is delayed for even one minute following reperfusion.”

The MRI-based study randomized 165 patients to postconditioning followed by PCI and stenting versus routine primary PCI and stenting. The postconditioning intervention consisted of four 30-second balloon inflations separated by 30 seconds of reperfusion. A total of 101 patients met final enrollment criteria and underwent MRI measurements of infarct size and myocardial salvage one to three days following PCI.

“Unfortunately, we found that the addition of postconditioning to primary PCI had no effect on infarct size and myocardial salvage. In the postconditioning group (n=53), mean infarct size was 21.1 g vs 20.4 g in the control group (n=48) and the myocardial salvage index was 16.8 in the postconditioning group and 15.9 in the control group. No benefit of postconditioning was observed when the data was stratified by ischemic times, sex or age,” Traverse said.
           
He is not entirely ready to abandon post-conditioning, although it is possible that the reperfusion injury described in animal models may not occur in humans. The research team is analyzing follow-up MRIs from these patients taken at three months and one year. “It is possible that we may see a delayed benefit of postconditioning on LV function since previous studies have not examined this later time point,” he explained.

For more information: www.mplsheart.com

Related Content

Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Mobility May Predict Elderly Heart Attack Survivors' Repeat Hospital Stays
News | Cath Lab | April 23, 2019
Determining which elderly heart attack patients take longer to stand from a seated position and walk across a room may...
FDA Releases New Guidance on Medical Devices Containing Nitinol
News | Cath Lab | April 18, 2019
April 18, 2019 — The U.S.
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.

Figure 2: Angiography demonstrates a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification (double-headed arrow) in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL (inset; note the cavitation bubbles generated by IVL [black arrows]). (D) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-IVL and coregistered to the OCT lens (white arrow in C) demonstrate multiple calcium fractures and large acute luminal gain. (E) Angiography demonstrates complete stent expansion with the semicompliant stent balloon (inset) without the need for high-pressure noncompliant balloon inflation. (F) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-stenting and coregistered to the OCT lens (arrow in E) demonstrate further fracture displacement (arrow), with additional increase in the acute area gain (5.17 mm2), resulting in full stent expansion and minimal malapposition.

Feature | Cath Lab | April 15, 2019 | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators
Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remai
BIOTRONIK’s PK Papyrus covered coronary stent. The stent ius used in emergency coronary artery dissections to repair the vessel wall.
Technology | Cath Lab | April 15, 2019
April 15, 2019 — Biotronik began its U.S.
Providing Follow-Up Care After Heart Attack Helps Reduce Readmissions, Deaths
News | Cath Lab | April 09, 2019
A program designed to help heart attack patients with the transition from hospital to outpatient care can reduce...
TherOx Receives FDA Approval for SuperSaturated Oxygen Therapy
Technology | Cath Lab | April 08, 2019
TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) granted premarket approval for its...
Cook Medical Recalls Transseptal Needle Due to Risk of Detached Plastic Fragments
News | Cath Lab | March 20, 2019
March 20, 2019 — Cook Medical is recalling one lot of its...
Overlay Init